Dr. Sarah Kleinstein received her Ph.D. in Molecular Genetics and Microbiology from Duke University, where she utilized next-generation sequencing techniques to investigate the role of human genetics in infectious disease pathogenesis, along with other complex traits. Her postdoctoral studies have included building next-generation sequencing capacity at the District of Columbia Public Health Laboratory and, currently, investigating the transcriptomics of neutrophils in type 2 diabetes at the J. Craig Venter Institute in La Jolla, CA. Additionally, Dr. Kleinstein has completed a CDC Emerging Infectious Diseases fellowship and has a M.S. in Genetic Epidemiology from the University of Washington, where she researched genetics of colorectal cancer. She has recently published in the fields of genetics and precision medicine and is passionate about mentorship and diversity in science.